Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration-论文-万方医学网

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration

导出原文传递

翻译打印收藏纠错

作者： Thoueille, Paul ^[1] ; Saldanha, Susana Alves ; Desfontaine, Vincent ; Kusejko, Katharina ; Courlet, Perrine ; Andre, Pascal ; Cavassini, Matthias ; Decosterd, Laurent A. ; Buclin, Thierry ; Guidi, Monia ; Swiss HIV Cohort Study

作者单位： PunchUp WorldMahidol Univ Mahidol University Mahidol Oxford Tropical Medicine Research Unit (MORU ^[1]

关键词 INTRACELLULAR PHARMACOKINETICS ANTIRETROVIRAL DRUGS DISOPROXIL FUMARATE INFECTED PATIENTS PLASMA SAFETY

发布时间 2024-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration

相似文献

相关期刊

检索历史清除